Antibacterial Resistance Leadership Group
@ARLGnetwork
Experts dedicated to prioritizing, designing, and executing clinical research that will reduce the public health threat of antibacterial resistance.
At #ESCMIDGlobal 2025, @ARLGnetwork Principal Investigator Vance Fowler, MD, MHS co-chaired a session on recent trials on S. aureus bacteremia management. Learn about ARLG’s studies on S. aureus & other ways the network is addressing #AMR: arlg.org/arlg-studies
ICYMI: The @ARLGnetwork July 2025 newsletter is now available on our website! Check out the new clinical site spotlights, recent publications, and more network news: arlg.org/newsletters
At #ESCMIDGlobal 2025, @ARLGnetwork member @davidantibiotic gave a keynote lecture, Asia: An AMR Hot Zone. He discussed the antimicrobial resistance crisis in Asia & strategies to address this global health issue. Learn how the network is addressing #AMR: arlg.org
The ESCAPED study completed enrollment! This study aimed to describe the S. aureus antimicrobial resistance patterns, risk factors, & antibiotic prescribing practices for patients in emergency depts with purulent skin & soft tissue infections. Learn more: arlg.org/arlg-studies
Congratulations to @ARLGnetwork Lab Center Associate Director Sarah B. Doernberg, MD, MAS who was named a 2025 Master Clinician by @UCSFDOM! This honor recognizes Dr. Doernberg’s clinical expertise, compassionate patient care, mentorship excellence, and interdisciplinary impact.
ICYMI: The @ARLGnetwork had a strong presence at #ESCMIDGlobal 2025! ARLG members presented, spoke, and chaired events at the internationally renowned event in #infectiousdisease. Check out a list of ARLG contributors: arlg.org/escmid-global-… @ESCMID
The @ARLGnetwork July 2025 newsletter was sent out today! Check your inbox for the latest network news and publications: duke.is/ARLG-07-2025-N… Didn't receive the newsletter? Subscribe to receive the next one! duke.is/ARLG-newslette…
Several @ARLGnetwork members presented, spoke, and chaired events at #ESCMIDGlobal 2025, an internationally renowned event in #InfectiousDisease. View a list of ARLG contributors and their session titles at arlg.org/escmid-global-…
The Abstract Book from #ESCMIDGlobal 2025 is now published in #CMIComms. It includes all abstracts presented in the scientific programme, marking over 5K abstracts! With a DOI, you can now cite your work presented at ESCMID Global 2025. 🎓 Check it out: ow.ly/xjHX50Wiebv
🗓️On Thursday, July 10, @ARLGnetwork member @davidantibiotic will share his expertise in a webinar on designing adaptive clinical trials.
Interested in learning how to design an adaptive clinical trial? Then this Ecraid webinar is just for you! The webinar will cover seamless trials, platform trials & more! 🗓️ Thurs, 10 July @ 11 CEST 🎟️Free 👀Learn more & register today! ow.ly/mAch50VW8nw
ICYMI: Registration and abstract submission is now open for the Global AMR Innovators Conference. The conference will be held October 1-3 in London, UK. Learn more and register: gamric.org
Abstract submission and registration are now open for #GAMRIC! Be sure to submit your original abstract before the deadline on 13 June. And with only 300 onsite tickets available, early registration is recommended to guarantee your place. gamric.org
ARLG Network member @davidantibiotic gave a keynote at #ESCMIDGlobal, Asia: An AMR hot zone. He discussed the antimicrobial resistance crisis in Asia and strategies to address this global health concern. Learn how the #ARLGnetwork is working to fight #AMR: arlg.org
Happening soon at #ESCMIDGlobal 2025! Don’t miss David Paterson’s powerful keynote lecture on "Asia: an AMR hot zone." Discover the impact of AMR in Asia, insights from the ACORN-HAI study, and key strategies to fight drug-resistant infections.
Recognizing Dr. Barbara E. Murray’s significant contributions to the field of #infectiousdisease, the #ARLGnetwork renamed our Early Stage Investigator award in her honor. Dr. Murray's commitment to the field will live on through researchers receiving this award.
Data published by #ARLGNetwork researchers found that rapid antibiotic susceptibility testing shows greater benefits in managing #GramNegative bacteremia caused by #AMR bacteria. Learn more: duke.is/ARLG-Pub-12-16… @ASMicrobiology
🎙️ New episode of #TheAMRStudio is out! We speak with Vance Fowler, co-lead of the @ARLGnetwork, about his decades research and the work of the ARLG. In the news, hear about our student's recent paper on a method to study AMR dynamics in farms, and more! uu.se/en/centre/upps…
Carbapenem-resistant Enterobacter pose a global public health threat, with limited studies on their clinical and molecular epidemiology. #ARLGNetwork researchers investigated these clones and how they can help tackle AMR: duke.is/ARLG-Pub-12-12… @JIDJournal
Research published by #ARLGNetwork members studied the development of Ledaborbactam (VNRX-5236), a promising β-lactamase inhibitor, as an oral combo with ceftibuten for UTI treatment. duke.is/ARLG-01127-24 @ASMicrobiology
A multicenter study completed by #ARLGNetwork researchers compared outcomes for patients with DTR Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam vs. ceftazidime-avibactam. duke.is/ARLG-00907-24 @ASMicrobiology
New publication alert: #ARLGNetwork researchers identified molecular mechanisms of meropenem–vaborbactam (MV) non-susceptibility in KPC-Klebsiella pneumoniae. Read more: duke.is/ARLG-Pub-08-24 @ASMicrobiology
Well done to Dr. Kerryl Greenwood-Quaintance on successfully defending her doctoral thesis and earning her Doctor of Education in Leadership from @smumn. Congratulations from the entire #ARLGNetwork!
The PHAGE trial, investigating phage therapy for reducing P. aeruginosa colony counts and its safety profile, has reached 80% enrollment! Recruitment is still ongoing—stay tuned as we approach full enrollment: duke.is/ARLG-Studies @NIAIDNews #ARLGnetwork
